Abstract

The objective of this study is to investigate and understand the oxidizing properties of a manganese oxide, specifically synthetic cryptomelane (KMn(8)O(16)) and its derivatives, in aqueous solution. Ciprofloxacin (CIP), a commonly used fluoroquinolone antibiotic, was used as the probe. Synthetic cryptomelane, known as octahedral molecular sieves (OMS-2), was synthesized, and its derivatives were prepared by adding transition metal oxides, V(2)O(5) or MoO(3), as dopants during synthesis. The solids were characterized by x-ray powder diffraction (XRD), SEM-energy-dispersive spectrometry (SEM-EDX), x-ray photoelectron spectroscopy (XPS), Fourier transform infrared spectra (FTIR), Raman spectra, and N(2)-Brunauer-Emmett-Teller method. Degradation of CIP by different doped OMS-2 was carried out. Process conditions were optimized using response surface methodology (RSM). XRD patterns indicated the crystal phase of regular and doped OMS-2 as the cryptomelane type. Presence of the dopants in doped cryptomelane was confirmed by SEM-EDX and XPS. FTIR and Raman results suggested that the dopants were substituted into the framework in place of manganese. SEM images, XRD analysis, and surface area analysis of doped OMS-2 indicated decreased particle size, decreased crystallinity, and increased surface area compared to regular OMS-2. Higher oxidizing reactivity of doped OMS-2 was also observed with increased CIP removal rates from aqueous solution. The enhancement of reactivity may be due to the increase of surface areas. Nine percent Mo/OMS-2, the most effective oxidant of all synthesized derivatives, was selected for optimization study. Favorable treatment conditions were obtained using RSM at pH 3 with molar ratio [9 % Mo/OMS-2]/[CIP] ≥ 50. Under such conditions, more than 90 % CIP can be removed in 30 min. The degradation kinetics was modeled by a modified first order rate with introduction of a retardation factor-α (R (2) > 0.98). Analysis of degradation products indicated that oxidation takes place mainly on the piperazine ring of CIP.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.